<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This investigation demonstrates an increase in endothelin (ET)-mediated vascular tone in peri-ischemic areas after experimental focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>) in the cat </plain></SENT>
<SENT sid="1" pm="."><plain>Adventitial application of the <z:chebi fb="0" ids="38118,50523">butenolide</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> PD155080 (30 microM), after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusions resulted in marked increases in caliber of dilated (10.6 +/- 1.6% change from preinjection baseline) and constricted vessels (68.7 +/- 17.5% change from pre-injection baseline) </plain></SENT>
<SENT sid="2" pm="."><plain>Cerebral blood flow (measured by laser Doppler flowmetry) was reduced after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion to 50% of preocclusion levels </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous administration of PD156707 30 min after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion restored cerebral blood flow to preocclusion baseline levels at 6 h </plain></SENT>
<SENT sid="4" pm="."><plain>The volume of ischemic damage in the cerebral hemisphere after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion was significantly reduced (by 45%) after intravenous administration of PD156707 </plain></SENT>
</text></document>